Possibility of personality changes after the pandemic

Written By : Isra Zaman

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-09-30 03:45 GMT | Update On 2022-09-30 07:12 GMT

Despite a long-standing hypothesis that personality traits are relatively impervious to environmental pressures, the COVID 19 pandemic may have altered the trajectory of personality across the United States, especially in younger adults, according to a new study published this week in the open-access journal PLOS ONE.

In the new study, the researchers used longitudinal assessments of personality from 7,109 people enrolled in the online Understanding America Study. They compared five-factor model personality traits-neuroticism, extraversion, openness, agreeableness and conscientiousness-between pre-pandemic measurements and assessments early or later in the pandemic. A total of 18,623 assessments, or a mean of 2.62 per participant, were analyzed.

Participants were 41.2% male and ranged in age from 18 to 109.

Consistent with other studies, there were relatively few changes between pre-pandemic and 2020 personality traits, with only a small decline in neuroticism. However, there were declines in extraversion, openness, agreeableness, and conscientiousness when 2021-2022 data was compared to pre-pandemic personality. The changes were about one-tenth of a standard deviation, which is equivalent to about one decade of normative personality change. The changes were moderated by age, with younger adults showing disrupted maturity in the form of increased neuroticism and decreased agreeableness and conscientiousness, and the oldest group of adults showing no statistically significant changes in traits.

Reference:

Sutin AR, Stephan Y, Luchetti M, Aschwanden D, Lee JH, Sesker AA, et al. (2022) Differential personality change earlier and later in the coronavirus pandemic in a longitudinal sample of adults in the United States. PLoS ONE 17(9): e0274542. https://doi.org/10.1371/journal.pone.0274542

Full View

Article Source : PLOS ONE

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Isra Zaman

Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Possibility of personality changes after the pandemic

Similar News

Glipizide and Metformin FDC - Effective, Safe and Cost-Effective in T2D: Latest Indian Real-World Study

Study Reveals Potassium-Rich Foods May Lower Irregular Heartbeat Risk

Study Reveals Daily Intake of Five Mushrooms May Reduce Alzheimer's and Heart Disease Risk

Managing Nasal Congestion in Allergic Rhinitis: Whats the Mechanism of Action of Allegra D ?

The Prediabetes Show, Episode 4: Metformin in Prediabetes - A Vaccination Pill for Diabetes Prevention in 65 Countries

WHO-Endorsed Mosquito Repellent Cuts Malaria Risk by Over 50 Percent: Study Finds

The Prediabetes Show Episode 3 - Tackling Patient Conversations around Prediabetes and Metformin

Groundbreaking New Study Shows Cells Can Revive From Death, Promote Tissue Regeneration